Supplementary Table 2: Univariate analysis of clinical outcome parameters
using the median value for each biomarker.
|
|
LRF |
DFS |
OS |
|||
|
|
HR (95% CI) |
p-value |
HR (95% CI) |
p-value |
HR (95% CI) |
p-value |
|
p16 |
0.21 (0.08 - 0.52) |
0.001 |
0.14 (0.06 - 0.32) |
<0.001 |
0.14 (0.06 - 0.33) |
<0.001 |
|
CD44 |
0.57 (0.24 - 1.31) |
0.2 |
0.53 (0.24 - 1.13) |
0.10 |
0.53 (0.25 - 1.14) |
0.11 |
|
c-MET |
0.45 (0.19 - 1.04) |
0.064 |
0.88 (0.41 - 1.88) |
0.8 |
0.67 (0.31 - 1.42) |
0.3 |
|
mTOR |
1.03 (0.45 - 2.35) |
>0.9 |
0.77 (0.36 - 1.65) |
0.5 |
0.77 (0.36 - 1.64) |
0.5 |
|
EGFR |
1.23 (0.54 - 2.82) |
0.6 |
0.57 (0.27 - 1.22) |
0.2 |
0.49 (0.23 - 1.05) |
0.069 |
|
GLUT1 |
1.23 (0.54 - 2.82) |
0.6 |
0.57 (0.27 - 1.22) |
0.2 |
0.57 (0.27 - 1.22) |
0.2 |